Karen A. Foster, who serves as Chief Quality and Operations at BioLife Solutions Inc (NASDAQ: BLFS), reported a sale of 2,577 shares of the company’s common stock on March 23, 2026, according to a Form 4 filing with the Securities and Exchange Commission.
The disposal was recorded at a weighted average price of $19.17 per share, producing total proceeds of $49,401. Transaction prices in the block ranged from $18.99 to $19.35. After the sale, Foster is listed as directly owning 108,758 shares of BioLife Solutions.
The filing notes the sale was carried out pursuant to a Rule 10b5-1 trading plan that Foster adopted on December 4, 2025. The use of a 10b5-1 arrangement is stated explicitly in the SEC filing.
The insider sale comes as BioLife’s stock trades roughly 7% above its 52-week low of $17.86, and the share price is down about 22% year-to-date. Market commentary included in the filing context cites InvestingPro analysis, which characterizes the stock as appearing overvalued at current levels, even as sell-side analysts continue to maintain price targets in the $30 to $34 range.
InvestingPro is referenced as offering 11 additional tips on BLFS, including notes on profitability expectations and valuation measures, along with a comprehensive Pro Research Report that covers the company’s key investment factors.
In separate corporate news disclosed alongside the transaction, BioLife Solutions reported fourth-quarter 2025 financial results that exceeded analysts’ expectations. The company posted earnings per share of $0.22 versus a consensus estimate of -$0.01, and reported revenue of $24.8 million compared with an expected $24.05 million.
Those quarterly figures are presented in the filing as evidence of the company beating market forecasts, with revenue and EPS both coming in above analysts’ projections for the period.
The combination of an insider sale executed under a prearranged trading plan, a stock trading near its yearly low and a quarter that outperformed expectations creates a mixed informational picture for investors and market watchers. The SEC Form 4 documents the mechanics and timing of Foster’s transactions, while the company’s reported results and third-party valuation commentary provide the surrounding financial context.